900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
symptôme de la région de la tête et du cou	Finding of head and neck region
Symptom severity NOS	Symptom severity (finding)
Symptom severity NOS	Symptom severity (finding)
épilepsie symptomatique	Epilepsy
Synchephalus twins	Syncephalus
Syncytial endometritis	Exaggerated placental site (morphologic abnormality)
Syngamus laryngeus	Mammomonogamus laryngeus
Synovial osteochondromatosis of other tarsal joint	Synovial osteochondromatosis
Synovial sarcoma - category	Synovial sarcoma
Syntactical aphasia	Syntactical aphasia (finding)
Synthetic antiandrogen	Antiandrogen
Synthetic patch repair	Repair - action
Syphilitic gumma of other sites	Syphilitic gumma
Syringing - action	Irrigation - action (qualifier value)
syringomyélobulbie	Syringomyelia and syringobulbia
Systemic chondromalacia	Relapsing polychondritis
Other acquired deformity of finger, NEC	Deformity of phalanx of finger or thumb
systemisch inflammatoir responssyndroom met orgaandisfunctie	Acute organ dysfunction due to systemic inflammatory response syndrome (disorder)
Systemic vascular resistance	Systemic vascular resistance (observable entity)
Systemic vascular resistance	Systemic vascular resistance (observable entity)
Systemic vascular resistance	Systemic vascular resistance (observable entity)
Systemic vascular resistance	Systemic vascular resistance (observable entity)
Sézary-syndroom met extranodale lokalisatie en/of lokalisatie in solide orgaan	Sézary's disease (disorder)
T-shaped fracture	T-shaped fracture
T-zone lymphoma	Peripheral T-cell lymphoma
stade T0	American Joint Committee on Cancer cT0 (qualifier value)
T1 (I): Cervical carcinoma confined to uterus	American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Endometrial tumor confined to corpus uteri	American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Trophoblastic disease confined to uterus	American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Tumor confined to vagina	American Joint Committee on Cancer cT1 (qualifier value)
T1 (I): Tumor limited to fallopian tube(s)	American Joint Committee on Cancer cT1 (qualifier value)
T1 (IA): Trophoblastic disease confined to uterus with no risk factors	American Joint Committee on Cancer cT1 (qualifier value)
T1 (IB): Trophoblastic disease confined to uterus with one risk factor	American Joint Committee on Cancer cT1 (qualifier value)
T1 (IC): Trophoblastic disease confined to uterus with two risk factors	American Joint Committee on Cancer cT1 (qualifier value)
stade T1	American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor < 2 cm in greatest dimension	American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor < 2 cm in greatest dimension without extraparenchymal extension	American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor confined to ethmoid with or without bone erosion	American Joint Committee on Cancer cT1 (qualifier value)
T1: Aerodigestive tract tumor confined to nasopharynx	American Joint Committee on Cancer cT1 (qualifier value)
T1: Breast tumor <= 2 cm in greatest dimension	American Joint Committee on Cancer cT1 (qualifier value)
T1: Clinically inapparent prostate tumor not palpable or visible by imaging	American Joint Committee on Cancer cT1 (qualifier value)
T1: Kidney tumor < 7.0 cm in greatest dimension limited to the kidney	American Joint Committee on Cancer cT1 (qualifier value)
T1: Lung tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus	American Joint Committee on Cancer cT1 (qualifier value)
T1: Solitary liver tumor < 2 cm; no vascular invasion	American Joint Committee on Cancer cT1 (qualifier value)
T1: Testicular tumor limited to the testis and epididymis without vascular/lymphatic invasion (tumor may invade tunica albuginea but not tunica vaginalis)	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor invades lamina propria or submucosa	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor invades submucosa (colon/rectum)	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to ampulla of Vater or sphincter of Oddi	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to ipsilateral parietal and/or visceral pleura	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to one subsite of hypo-pharynx and < 2 cm in greatest dimension	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to pancreas and < 2 cm in greatest dimension	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to subglottis	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to the antral mucosa with no erosion or destruction of bone	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor limited to vocal cord(s) (may involve anterior or posterior commissure) with normal mobility	American Joint Committee on Cancer cT1 (qualifier value)
T1: Tumor size < 1 cm, limited to thyroid	American Joint Committee on Cancer cT1 (qualifier value)
T1: Urinary tract tumor invades subepithelial connective tissue	American Joint Committee on Cancer cT1 (qualifier value)
T1a (IA): Invasive carcinoma of uterine cervix diagnosed by microscopy only	cT1a
T1a (IA): Tumor limited to endometrium	cT1a
T1a (IA): Tumor limited to one fallopian tube without penetrating the serosal surface, no ascites	cT1a
T1a (IA): Tumor limited to one ovary, capsule intact, no tumor on ovarian surface	cT1a
T1a1 (IA1): Tumor of uterine cervix with stromal invasion < 3.0 mm in depth and horizontal spread < 7.0 mm	American Joint Committee on Cancer cT1a1 (qualifier value)
T1a2 (IA2): Tumor of uterine cervix with stromal invasion > 3.0 mm but < 5.0 mm in depth and horizontal spread < 7.0 mm	American Joint Committee on Cancer cT1a2 (qualifier value)
T1a: Breast tumor >0.1 cm but <= 0.5 cm in greatest dimension	cT1a
T1a: Esophagus/stomach tumor invades lamina propria	cT1a
T1a: Prostate tumor incidental histologic finding in 5 percent or less of tissue resected	cT1a
T1a: Tumor limited to one vocal cord	cT1a
T1b (IB): Endometrial tumor invades up to or less than one half of the endometrium	cT1b
T1b (IB): Tumor limited to both ovaries: capsule intact, no tumor on ovarian surface	cT1b
T1b (IB): Tumor limited to both tubes without penetrating the serosal surface: no ascites	cT1b
T1b (IB): Tumor of uterine cervix with clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2	cT1b
T1b1 (IB1): Tumor of uterine cervix, clinically visible lesion < 4.0 mm in greatest dimension	American Joint Committee on Cancer cT1b1 (qualifier value)
T1b2 (IB2): Tumor of uterine cervix, clinically visible lesion > 4.0 mm in greatest dimension	American Joint Committee on Cancer cT1b2 (qualifier value)
T1b: Breast tumor >0.5 cm but <= 1 cm in greatest dimension	cT1b
T1b: Esophagus/stomach tumor invades submucosa	cT1b
T1b: Prostate tumor incidental histologic finding in greater than 5 percent of tissue resected	cT1b
T1b: Tumor involves both vocal cords	cT1b
T1c (IC): Endometrial tumor invades to more than one half of the endometrium	American Joint Committee on Cancer cT1c (qualifier value)
T1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings: OVARY: Resection	American Joint Committee on Cancer cT1c (qualifier value)
T1c (IC): Tumor limited to one or both tube(s) with extension into or through the tubal serosa; or with malignant cells in ascites or peritoneal washings: FALLOPIAN TUBE: Salpingectomy	American Joint Committee on Cancer cT1c (qualifier value)
T1c: >1 cm but <= 2 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy	American Joint Committee on Cancer cT1c (qualifier value)
T1c: Tumor identified by needle biopsy because of elevated prostate specific antigen: PROSTATE: Biopsy/transurethral resection: PROSTATE: Resection	American Joint Committee on Cancer cT1c (qualifier value)
T1mic: Microinvasion <= 0.1 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy	cT1mi
T2 (II): Endometrial tumor invades cervix, but does not extend beyond uterus	cT2
T2 (II): Fallopian tube tumor involves one or both tube(s) with pelvic extension	cT2
T2 (II): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but is limited to the genital structures (adnexa, vagina, broad ligament)	cT2
T2 (II): Tumor of uterine cervix invades beyond the uterus but not to pelvic wall or to lower third of vagina	cT2
T2 (II): Vaginal tumor invades paravaginal tissues but not to pelvic wall	cT2
T2 (IIA): Trophoblast: gestational trophoblastic tumor involving genital structure without risk factors	cT2
T2 (IIB): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but limited to genital structures with one risk factor	cT2
T2 (IIC): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but limited to genital structures with two risk factors	cT2
stade T2	cT2
T2: tumeur du tractus aérodigestif supérieur mesurant entre 2 et 4 cms	cT2
T2: Aerodigestive tract tumor > 2 cm but < 4 cm in greatest dimension without extraparenchymal extension	cT2
T2: Aerodigestive tract tumor causing bone erosion or destruction, except for the posterior antral wall, including extension into hard palate and/or middle nasal meatus	cT2
T2: Aerodigestive tract tumor extends into nasal cavity	cT2
T2: Aerodigestive tract tumor extends to soft tissue of oropharynx and/or nasal fossa	cT2
T2: Aerodigestive tract tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility	cT2
T2: Aerodigestive tract tumor extends to vocal cord(s) with normal or impaired mobility	cT2
T2: Aerodigestive tract tumor invades more than one subsite of hypopharynx or an adjacent site, or measures > 2 cm but < 4 cm in greatest dimension, without fixation of hemilarynx	cT2
T2: Aerodigestive tract tumor invades mucosa of >1 adjacent subsite of supraglottis/glottis/region outside supraglottis, (mucosa of base of tongue/vallecula/medial wall of piriform sinus) without fixation of larynx	cT2

Start Previous Page 132 of 155 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
7237811000172118	referentieset voor associaties betreffende vervangende concepten	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Belgian module (core metadata concept)